Identification of Ruzurgi:
No description |
Search images on Google Product Monograph
Active Ingredients:
- amifampridine, 10 MG
DIN: 02503034
Dosage Form(s): TABLET
Route(s) of Administration: ORAL
Description: IN ACCORDANCE WITH THE FCA DECISION IN A-78-22, THE 2021-06-24 DECISION (DATA PROTECTION) WAS RESTORED, AND A NEW NOC WAS ISSUED.
Schedule: Prescription
Company: MEDUNIK CANADA
ATC:
- N07 - OTHER NERVOUS SYSTEM DRUGS (ATC, WHO, Wiki)
- N07X - OTHER NERVOUS SYSTEM DRUGS (ATC, WHO)
- N07XX - Other nervous system drugs (ATC, WHO)
- N07XX05 - AMIFAMPRIDINE (WHO)